BMA raises concerns over RCPCH State of Child Health 2026 report
The British Medical Association has issued a response to the RCPCH State of Child Health 2026 report, citing a worrying decline in UK children's health.
Medical experts express concern
The British Medical Association (BMA) has reacted to the latest findings published by The Royal College of Paediatrics and Child Health (RCPCH). The 2026 report, titled the State of Child Health, highlights significant challenges facing the paediatric sector across the United Kingdom.
Professor David Strain, the BMA board of science chair, and Dr Heather Grimbaldeston, chair of the BMA public health medicine committee, addressed the implications of the data. They noted that the findings present a troubling outlook for the wellbeing of the nation's youngest citizens.
This report paints a worrying picture of children's health in the UK.
The State of Child Health findings
The RCPCH report serves as a critical assessment of the physiological and social determinants affecting children. While specific statistics from the 2026 dataset remain under detailed review by medical bodies, the consensus from BMA leadership suggests a systemic issue within the current healthcare landscape.
The response from the BMA focuses on the following areas of concern:
- The overall trajectory of paediatric health metrics in the UK.
- The capacity of public health systems to meet the needs of growing childhood illnesses.
- The socio-economic factors influencing long-term health outcomes for children.
Impact on public health policy
Medical professionals are calling for a direct response to the trends identified in the RCPCH study. The BMA's stance emphasises that the current data requires urgent attention from policymakers to prevent further deterioration in child health standards.
The findings are expected to influence upcoming discussions regarding paediatric resource allocation and public health funding. The BMA intends to use this evidence to advocate for structural changes that prioritise early intervention and improved access to specialist paediatric care.
